prediabetic state Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (10)

Phase 1 (1)
Phase 1/2 (1)
Unknown (8)

Interventional (6)
Observational (3)

Centre Hospitalier Universitaire de la Réunion (1)
Foundation of Cardiovascular Research and Education Enschede (1)
Joslin Diabetes Center (1)
Mayo Clinic (1)
Sunnybrook Health Sciences Centre (1)
The University of Texas Health Science Center at San Antonio (1)
University Hospital, Toulouse (1)
University of Alberta (1)
University of California, Davis (1)

No (7)
Yes (3)

No (10)

Adult (18+) (10)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadglucose intolerance

I am/have/haddiabetes

I am/have/hadprediabetic state

I am/have/hadtype 2 diabetes mellitus

I am/have/hadfasting

I am/have/hadimpaired glucose tolerance

I am/have/hadinsulin

I am/have/hadcardiovascular disease

I am/have/hadplasma glucose

I am/have/hadheart disease

I am/have/hadoral glucose tolerance test

I am/have/hadfasting blood glucose

I am/have/hadinsulin sensitivity

I am/have/hadstroke

I am/have/hadangina pectoris

I am/have/hadhypoglycemia

I am/have/hadbody mass index

I am/have/hadhyperglycemia

I am/have/hadcaloric restriction

I am/have/hadacute coronary syndrome

added new label for I am/have/had

I am looking for

I am looking forglycosylated hemoglobin

I am looking forhemoglobin a1c

I am looking forinsulin

I am looking forhdl cholesterol

I am looking forblood sugar

I am looking foreverolimus

I am looking forlipoprotein cholesterol

I am looking forLDL Cholesterol

I am looking forhba1c

I am looking forsglt2

added new label for I am looking for

Advanced Filters

Found 186 clinical trials

None

None views

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Cardiovascular Diseases
Recruiting

SGLT2 Inhibition in Older Obese Adults With Pre-diabetes

Inhibitors of the sodium-glucose co-transporter (SGLT2) are FDA-approved for the treatment of type 2 diabetes (T2DM). Their mechanism of action involves lowering of blood glucose concentration secondary to increased glucose excretion of glucose by the kidney. These drugs also improve body weight, blood pressure, and cardiac function. Based on these …

oral glucose tolerance test

hemoglobin a1c

blood sugar

cognitive assessment

type 2 diabetes mellitus

0 views
19 Feb, 2024
2 locations

Phase 1
For adults
Recruiting in 10s
Interventional Study
all
not recruiting

Effect of 1 25-dihydroxyvitamin D3 Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons

The aim of this study is to assess the effects of 1,25(OH)2D3 on insulin secretion by the pancreas and glucose utilization by skeletal muscle as well as to determine the effects of 1,25(OH)2D3 on muscle strength in pre-diabetic persons

serum glucose

insulin

prediabetic state

fasting

body mass index

0 views
19 Feb, 2024
1 location

For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Incidence of Diabetes and Metabolic Disorders After TIPS in Cirrhotic Patients

Based on our retrospective data, TIPS induces in 30% of cirrhotic patients metabolic disorders associated with diabetes or pre-diabetes. The main objective is to measure the cumulative incidence of diabetes and pre-diabetes 6 months after TIPS insertion.

0 views
19 Feb, 2024
1 location